Form 4 for AEON AEON Biopharma, Inc.

Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-31 · accession 0001104659-24-097067 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-09-04	2024-08-31	AEON	Forth Marc	Chief EXECTUIVE Off, Dir	A - Grant	$0.00	+470.7K	750.5K	+168%	$0
D	2024-09-04	2024-08-31	AEON	Forth Marc	Chief EXECTUIVE Off, Dir	A - Grant	$0.00	+1.26M	1.26M	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-08-31	A	A	470,692	$0.00	750,547	D	—	—	(F1) Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date. (F2) Includes an award of restricted stock units ("RSUs") in the amount of 279,855 previously granted on April 26, 2023, which were previously reported on July 24, 2023 as derivative securities in Table II due to a clerical error, and which are now being reported as common stock in Table I. The vesting terms for the RSUs have not changed from what was previously reported on July 24, 2023.
2	Derivative	Stock Option	2024-08-31	A	A	1,256,062	$0.00	1,256,062	D	$0.83 · — to 2034-08-30	1,256,062 Class A Common Stock	(F3) Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.